Clinical Considerations for Using Newer Antibiotics for Gram-Negative Infections
September 17th 2025Ryan Shields, PharmD, MS, discusses the challenges of incorporating newer antibiotics for Gram-negative infections, how he is using broad-spectrum antimicrobial agents for these infections, and the factors he looks for in considering new agents.
Adoption of Rapid Diagnostic Tools, Susceptibility Testing for Gram-Negative Infections
September 15th 2025Rodney E. Rohde, PhD, SV/SM/MB(ASCP)CM, FACSc, offers some insights on the latest diagnostics, susceptibility testing for newer antimicrobials, and how infectious disease clinicians and laboratory professionals can collaborate on challenging cases.
DRC Ebola Outbreak: Ring Vaccination Begins in Kasai’s Bulape as Response Scales Up
Published: September 15th 2025 | Updated: September 15th 2025Democratic Republic of the Congo reports 28 suspected cases and 15 deaths, as Africa CDC and WHO mobilize vaccines, surveillance, and rapid response teams to contain the 16th Ebola outbreak since 1976.
Social Determinants, Health Literacy Factor in Noncommunicable Diseases, Subsequent Infections
September 11th 2025In the second installment of an interview with Jacinda Abdul-Mutakabbir, PharmD, MPH, she continues the discussion around limited to no health care engagement due to these factors, and the importance of translating data from the bench to bedside when looking at disease and infection prevention.
Are There Benefits to Combination Therapy for Drug-Resistant Pseudomonas Infections?
September 9th 2025Pranita Tamma, MD, MHS, continues her conversation about a study she was involved in that compared ceftolozane-tazobactam and ceftazidime-avibactam. She discusses how an analysis of infection source and treatment patterns found no evidence that combination therapy improves outcomes in patients with drug-resistant Pseudomonas, consistent with prior studies and clinical trials.
Implementation Science Builds Partnerships to Create Better Access to Healthcare
September 8th 2025Michael Herce, MD, MPH, MSCR, discusses this concept and how it works to improve access to healthcare for populations who have been disproportionately burdened by various infectious diseases such as HIV, tuberculosis, and COVID-19.
CDC Reports Outbreak of Neisseria meningitidis Conjunctivitis Among Military Trainees in Texas
September 8th 202541 cases of nongroupable N meningitidis conjunctivitis were identified at Joint Base San Antonio-Lackland, highlighting diagnostic, treatment, and surveillance implications for congregate living settings.